Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma.

There is increasing experimental evidence to suggest that expression of O6-alkylguanine-DNA-alkyltransferase (ATase) is a major factor in resistance to dacarbazine (DTIC). We recently demonstrated a progressive ATase depletion in human peripheral lymphocytes with nadir levels occurring at 4-6 h afte...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, S. M., Margison, G. P., Woodcock, A. A., Thatcher, N.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968509/
https://www.ncbi.nlm.nih.gov/pubmed/8512821

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968509/
https://www.ncbi.nlm.nih.gov/pubmed/8512821

Ejemplares similares